Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hemispherx Biopharma, Inc. 2nd Quarter 2010 Financial Results
Yahoo/GlobeNewsWire
Saturday, August 7, 2010 - 11:45am
tags:
Hemispherx, earnings, investors
Amylin Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Saturday, August 7, 2010 - 11:44am
tags:
Amylin, investors
Osiris swings to 2Q profit
bizjournals.com
Saturday, August 7, 2010 - 11:42am
tags:
Osiris Therapeutics, earnings
GenVec says new Novartis deal could yield $13M
Yahoo/AP
Friday, August 6, 2010 - 11:48am
tags:
Novartis, GenVec
What Investors Think About Abraxis BioScience
Motley Fool
Friday, August 6, 2010 - 11:47am
tags:
companies
Osiris Therapeutics turns 2Q profit, expenses fall
Yahoo/AP
Friday, August 6, 2010 - 11:46am
tags:
Osiris Therapeutics, earnings
Ardea takes larger 2Q loss on development costs
Yahoo/AP
Friday, August 6, 2010 - 11:26am
tags:
earnings, Ardea
Cypress rebuffs Ramius buyout offer
Fierce Biotech
Friday, August 6, 2010 - 11:24am
tags:
Cypress Bioscience, Ramius, M&A
Arena Pharma plans stock offering to raise $60M
Yahoo/AP
Friday, August 6, 2010 - 11:07am
tags:
Arena Pharmaceuticals, stock offering
Teva copy of Sanofi blood thinner is close -analyst
Reuters
Friday, August 6, 2010 - 11:01am
tags:
Teva Pharmaceuticals, blood thinners, Lovenox, generics, Sanofi
Big Pharma Paying Healthy Dividends
Yahoo/IndieResearch
Friday, August 6, 2010 - 10:58am
tags:
dividends, Big Pharma, Pfizer, JNJ, GSK, Eli Lilly, Roche, Merck
[video]No Shortage of Suitors for Genzyme
Yahoo/Morningstar
Friday, August 6, 2010 - 10:57am
tags:
Genzyme, M&A, GSK, JNJ, Sanofi
What Investors Think About Abbott Laboratories
Motley Fool
Friday, August 6, 2010 - 10:54am
tags:
Abbott Laboratories, investors
Seattle Genetics: The Busy Season Is Set to Begin
Seeking Alpha
Friday, August 6, 2010 - 7:58am
tags:
Seattle Genetics
Vectura Licenses Patents To GlaxoSmithKline
WSJ Online
Friday, August 6, 2010 - 7:57am
tags:
Vectura, licensing, GSK
Merck Looks East
Seeking Alpha
Friday, August 6, 2010 - 7:55am
tags:
Merck, partnerships, Sinopharm, China
Bayer’s Pill of Peril: Birth Control Lawsuits Double to 2,000
BNET Pharma
Friday, August 6, 2010 - 7:30am
tags:
Bayer, lawsuits, birth control pill, Yaz, Teva Pharmaceuticals
Roche Wins Reversal of $10.5 Million Accutane Verdict in New Jersey Case
Bloomberg
Friday, August 6, 2010 - 7:29am
tags:
Roche, lawsuits, Accutane
ArQule: Warming Up or Cooling Off?
Motley Fool
Friday, August 6, 2010 - 7:28am
tags:
Arqule
3 Hearty Healthcare Investments
Investopedia
Friday, August 6, 2010 - 7:26am
tags:
Pfizer, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.